—  SHORT COURSE  —

THE VALUE OF IMMUNOHISTOCHEMISTRY
IN THE ASSESSMENT OF BONE MARROW DISORDERS

Attilio Orazi, M.D., FRCPath. and Dennis P. O'Malley, M.D.




BCL-2

BCL-2 is a monoclonal antibody developed in mice to the human BCL-2 oncoprotein. It is most effective demonstrated by heat-induced epitope retrieval techniques. It works well in either formalin or B5 fixed tissues and is resistant to acid decalcification. In our hands it appears to work better in B5 than in formalin.

The BCL2 stain can be used to distinguish follicular lymphocytes from reactive follicular hyperplasia in bone marrow. However, the effective value of this approach is still controversial (Fakan et al, 1996).

References

  • Ben-Ezra JM et al. Staining for Bcl-2 protein helps to distinguish benign from malignant lymphoid aggregates in bone marrow biopsies. Mod Pathol. 1994 ;7:560-4.
  • Chetty et al: Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma. J Clin Pathol. 1995; 48:1035-8.
  • Fakan et al: Expression of bcl-2 protein in distinguishing benign from malignant lymphoid aggregates in bone marrow biopsies. Gen Diagn Pathol. 1996;141:359-63.